These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15284359)

  • 21. Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia.
    Scolari MP; Stefoni S; Mosconi G; Feliciangeli G; Colì L; Bonomini V
    Life Support Syst; 1983; 1(1):51-60. PubMed ID: 6678371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
    Akizawa T; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis.
    Wong CK; Szeto CC; Chan MH; Leung CB; Li PK; Lam CW
    Immunol Invest; 2007; 36(1):47-57. PubMed ID: 17190649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
    Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
    Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itchy skin--a clinical problem for haemodialysis patients.
    Wikström B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v3-7. PubMed ID: 17586843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.
    Enia G; Panuccio V; Cutrupi S; Pizzini P; Tripepi G; Mallamaci F; Zoccali C
    Nephrol Dial Transplant; 2007 Feb; 22(2):538-44. PubMed ID: 17082213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.
    Chiu YL; Chen HY; Chuang YF; Hsu SP; Lai CF; Pai MF; Yang SY; Peng YS
    Nephrol Dial Transplant; 2008 Nov; 23(11):3685-9. PubMed ID: 18515654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EEG studies in uraemic patients during extracorporeal haemodialysis or intermittent peritoneal dialysis.
    Zysno E; Reichenmiller HE; Dürr F
    Electroencephalogr Clin Neurophysiol; 1967 Oct; 23(4):384. PubMed ID: 4167790
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of pretransplant serum cytokine levels in renal transplant recipients.
    Berber I; Yiğit B; Işitmangil G; Tellioğlu G; Ozgezer T; Gülle S; Türkmen F; Titiz I
    Transplant Proc; 2008; 40(1):92-3. PubMed ID: 18261555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemoperfusion in the management of end-stage renal disease.
    Winchester JF
    Life Support Syst; 1984; 2(2):107-11. PubMed ID: 6384670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of MIA syndrome in peritoneal dialysis patients].
    Tasić D
    Med Pregl; 2007; 60 Suppl 2():170-2. PubMed ID: 18928187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.